Waymade Australia Pty Ltd

Regulatory activities for this sponsor.

2 result(s) found, displaying 1 to 2

AusPAR: Trientine dihydrochloride

6 April 2021

Australian Public Assessment Report (AusPAR)

Australian Public Assessment Report for Trientine dihydrochloride
Trientine Waymade

25 January 2021

Prescription medicine decision summary

TGA decision: Trientine Waymade (trientine dihydrochloride) is approved to treat Wilson's disease patients intolerant to penicillamine.